Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Screening of Individuals Diagnosed With Type 2 Diabetes and the Impact of a Multidomain Intervention Targeting Cognitive Decline (The Brain Care Study)

NCT07250789 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT07250789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07250789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Screening of Individuals Diagnosed With Type 2 Diabetes and the Impact of a Multidomain Intervention Targeting Cognitive Decline (The Brain Care Study)
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2024
Completion date
June 30, 2029
Enrollment
420 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, cognitive impairment, diabetes, diabetes mellitus type 2, type 2 diabetes, type 2 diabetes mellitus (t2dm)